RVTY logo

Revvity Inc. (RVTY)

$155.11

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on RVTY

Market cap

$17.31B

EPS

2.09

P/E ratio

73.7

Price to sales

5.91

Dividend yield

0.181%

Beta

1.080399

Price on RVTY

Previous close

$150.83

Today's open

$150.83

Day's range

$149.38 - $158.96

52 week range

$81.22 - $171.74

Profile about RVTY

CEO

Prahlad R. Singh

Employees

11000

Headquarters

Waltham, MA

Exchange

New York Stock Exchange

Shares outstanding

111586401

Issue type

Common Stock

RVTY industries and sectors

Healthcare

Biotechnology & Life Sciences

News on RVTY

All You Need to Know About Revvity (RVTY) Rating Upgrade to Buy

Revvity (RVTY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

news source

Zacks Investment Research • Nov 6, 2026

news preview

Madison Mid Cap Fund Q3 2026 Portfolio Activity

The Madison Mid Cap Fund (Class I) returned -2.09% in the third quarter, compared to the Russell Midcap Index return of -3.00%. The top five contributors for the quarter were Gartner, Medpace Holdings, Ross Stores, Revvity, and Waters Corporation. The bottom five detractors for the quarter were MKS, Floor & Decor Holdings, Carlisle Companies, Moelis and Co., and Glacier Bancorp.

news source

Seeking Alpha • Nov 6, 2026

news preview

Revvity Q3 Earnings Call Highlights

Revvity NYSE: RVTY reported third-quarter results that exceeded its expectations, supported by stronger demand in its Life Sciences segment, continued growth in Diagnostics and expanding interest in artificial intelligence-related research tools.

news source

MarketBeat • Nov 4, 2026

news preview

Revvity Faced Off With 'Elevated Investor Expectations' — And Won

Medical research stock Revvity surged on the back of a strong third-quarter report and heightened 2026 view.

news source

Investors Business Daily • Nov 3, 2026

news preview

Revvity, Inc. (RVTY) Q3 2026 Earnings Call Transcript

Revvity, Inc. (RVTY) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 3, 2026

news preview

Revvity Announces Financial Results for the Third Quarter of 2026

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today reported financial results for the third quarter ended October 4, 2026. The Company reported GAAP earnings per share from continuing operations of $0.56, as compared to $0.41 in the same period a year ago. Revenue for the quarter was $729 million, as compared to $699 million in the same period a year ago. GAAP operating income from continuing operations for the quarter was $95 million, as compared to $82 million for the same per.

news source

Business Wire • Nov 3, 2026

news preview

Revvity (RVTY) Tops Q3 Earnings and Revenue Estimates

Revvity (RVTY) came out with quarterly earnings of $1.38 per share, beating the Zacks Consensus Estimate of $1.29 per share. This compares to earnings of $1.18 per share a year ago.

news source

Zacks Investment Research • Nov 3, 2026

news preview

RVTY Q3 Earnings Beat Estimates on Life Sciences Strength, '26 View Up

Revvity's Q3 2026 earnings and revenues beat estimates, fueled by Life Sciences growth and margin expansion, prompting an upward revision to its annual outlook.

news source

Zacks Investment Research • Nov 3, 2026

news preview

Revvity Board Declares Quarterly Dividend

WALTHAM, Mass.--(BUSINESS WIRE)--The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This dividend is payable on February 12, 2027 to all shareholders of record at the close of business on January 22, 2027. About Revvity At Revvity, “impossible” is inspiration, and “can't be done” is a call to action. Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows fr.

news source

Business Wire • Oct 30, 2026

news preview

Revvity Gears Up to Post Q3 Earnings: What's in Store for the Stock?

RVTY's Q3 earnings may gain from recovering pharma demand, stronger HCS demand and software growth, despite lingering spending and TB-related headwinds.

news source

Zacks Investment Research • Oct 30, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Revvity Inc.

Open an M1 investment account to buy and sell Revvity Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in RVTY on M1